CCT
BMY icon

Chemung Canal Trust’s Bristol-Myers Squibb BMY Stock Holding History

Chemung Canal Trust’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.3M Buy
74,587
+3,831
+5% +$220K 0.79% 34
2026
Q1 		$4.29M Buy
70,756
+29,413
+71% +$1.71M 0.87% 36
2025
Q4 		$2.23M Sell
41,343
-1,673
-4% -$80.5K 0.44% 59
2025
Q3 		$1.94M Buy
43,016
+2,939
+7% +$137K 0.39% 60
2025
Q2 		$1.86M Sell
40,077
-75
-0.2% -$3.68K 0.39% 60
2025
Q1 		$2.45M Sell
40,152
-774
-2% -$45.1K 0.54% 53
2024
Q4 		$2.31M Sell
40,926
-125
-0.3% -$6.98K 0.48% 55
2024
Q3 		$2.12M Buy
41,051
+581
+1% +$27.3K 0.43% 55
2024
Q2 		$1.68M Sell
40,470
-542
-1% -$24.3K 0.33% 64
2024
Q1 		$2.22M Buy
41,012
+1,604
+4% +$81.7K 0.43% 56
2023
Q4 		$2.02M Sell
39,408
-5,780
-13% -$303K 0.42% 51
2023
Q3 		$2.62M Sell
45,188
-6,242
-12% -$382K 0.6% 49
2023
Q2 		$3.29M Sell
51,430
-52,085
-50% -$3.49M 0.71% 46
2023
Q1 		$7.17M Sell
103,515
-392
-0.4% -$27.6K 1.65% 18
2022
Q4 		$7.48M Buy
103,907
+2,700
+3% +$204K 1.7% 16
2022
Q3 		$7.2M Sell
101,207
-448
-0.4% -$32.5K 1.79% 14
2022
Q2 		$7.83M Buy
101,655
+785
+0.8% +$59.8K 1.79% 15
2022
Q1 		$7.37M Buy
100,870
+57,666
+133% +$3.87M 1.43% 25
2021
Q4 		$2.69M Sell
43,204
-63,514
-60% -$3.73M 0.49% 58
2021
Q3 		$6.31M Buy
106,718
+8,086
+8% +$533K 1.21% 33
2021
Q2 		$6.59M Buy
98,632
+58,403
+145% +$3.81M 1.26% 32
2021
Q1 		$2.54M Sell
40,229
-86,063
-68% -$5.35M 0.51% 63
2020
Q4 		$7.83M Buy
126,292
+12,908
+11% +$794K 1.65% 18
2020
Q3 		$6.84M Buy
113,384
+17,821
+19% +$1.07M 1.63% 21
2020
Q2 		$5.62M Sell
95,563
-1,662
-2% -$99.4K 1.47% 21
2020
Q1 		$5.42M Sell
97,225
-3,450
-3% -$211K 1.66% 21
2019
Q4 		$6.46M Buy
100,675
+14,444
+17% +$827K 1.47% 20
2019
Q3 		$4.37M Buy
86,231
+46,710
+118% +$2.2M 1.06% 37
2019
Q2 		$1.79M Sell
39,521
-225
-0.6% -$10.5K 0.42% 63
2019
Q1 		$1.9M Buy
39,746
+104
+0.3% +$5.18K 0.45% 58
2018
Q4 		$2.06M Sell
39,642
-3,352
-8% -$180K 0.59% 50
2018
Q3 		$2.67M Buy
42,994
+500
+1% +$29.7K 0.59% 55
2018
Q2 		$2.35M Sell
42,494
-68,435
-62% -$3.7M 0.57% 50
2018
Q1 		$7.02M Buy
110,929
+2,227
+2% +$143K 1.68% 25
2017
Q4 		$6.66M Sell
108,702
-230
-0.2% -$14.4K 1.45% 29
2017
Q3 		$6.94M Buy
108,932
+28,653
+36% +$1.67M 1.58% 24
2017
Q2 		$4.47M Buy
80,279
+6,356
+9% +$346K 1.04% 35
2017
Q1 		$4.02M Sell
73,923
-8,459
-10% -$464K 0.94% 40
2016
Q4 		$4.81M Sell
82,382
-17,296
-17% -$946K 1.13% 33
2016
Q3 		$5.38M Sell
99,678
-43,324
-30% -$2.78M 1.27% 29
2016
Q2 		$10.5M Sell
143,002
-33,106
-19% -$2.34M 2.5% 9
2016
Q1 		$11.2M Buy
176,108
+12,035
+7% +$759K 2.59% 7
2015
Q4 		$11.3M Buy
164,073
+51,397
+46% +$3.4M 2.6% 7
2015
Q3 		$6.67M Sell
112,676
-2,737
-2% -$174K 1.62% 18
2015
Q2 		$7.68M Sell
115,413
-114
-0.1% -$7.51K 1.68% 18
2015
Q1 		$7.45M Sell
115,527
-2,613
-2% -$164K 1.53% 20
2014
Q4 		$6.97M Sell
118,140
-1,687
-1% -$95.1K 1.4% 23
2014
Q3 		$6.13M Sell
119,827
-855
-0.7% -$42.7K 1.27% 29
2014
Q2 		$5.85M Sell
120,682
-3,925
-3% -$193K 1.16% 29
2014
Q1 		$6.47M Sell
124,607
-1,200
-1% -$63.9K 1.33% 24
2013
Q4 		$6.69M Sell
125,807
-475
-0.4% -$24.2K 1.38% 20
2013
Q3 		$5.84M Sell
126,282
-202
-0.2% -$8.87K 1.27% 24
2013
Q2 		$5.65M Buy
+126,484
New +$5.49M 1.26% 28

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Chemung Canal Trust's BMY Position: Q2 2026 in Review

Chemung Canal Trust increased its Bristol-Myers Squibb (BMY) stake by 5.4% in Q2 2026, buying an estimated $220K and bringing the position to 74,587 shares worth $4.3M. The position accounts for 0.79% of the portfolio, ranked #34.

Chemung Canal Trust first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.3M in Q4 2015. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Chemung Canal Trust held 74,587 shares of Bristol-Myers Squibb worth $4.3M as of Q2 2026.
  • Chemung Canal Trust bought 3,831 Bristol-Myers Squibb shares in Q2 2026, an estimated $220K.
  • Bristol-Myers Squibb made up 0.79% of Chemung Canal Trust's portfolio in Q2 2026, its #34 holding.
  • Chemung Canal Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Chemung Canal Trust's Bristol-Myers Squibb position peaked at $11.3M in Q4 2015.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Chemung Canal Trust's 13F filing for Q2 2026, filed 15 Jul 2026.